© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection
aDivision of Cardiac Surgery, Department of Surgery, University of Leicester, Glenfield Hospital, Leicester LE3 9QP, UK
bDepartment of Cell Physiology and Pharmacology, University of Leicester, Leicester LE1 7RH, UK
* Corresponding author
Background: There are data supporting the existence of ischemic preconditioning in man. This study investigated the most effective preconditioning protocol for the human myocardium and whether the second window of ischemic preconditioning (24 h) is as protective as the first window (
2 h). Methods and results: Right atrial appendages (n=6/group) obtained during coronary bypass surgery were prepared and superfused with normoxic and normothermic Krebs–Henseleit solution. After 30 min stabilisation, muscles were subjected to various preconditioning protocols followed by 90 min ischemia and 120 min reperfusion. At the end of each protocol, the leakage of creatinine kinase (CK, U/g wet wt) and the reduction of MTT to insoluble formazan dye (OD/mg wet wt), an index of cell viability, were measured. In study 1, preconditioning was induced by 2, 3, 5 and 10 min of ischemia followed by 5 min reperfusion. In study 2, 1–4 cycles of 2 or 5 min ischemia–5 min reperfusion were applied. In study 3, preconditioning was induced by 5 min ischemia–5 min reperfusion followed by 1, 2, 3 or 4 h reperfusion before the subsequent 90 min ischemia. In study 4, preconditioning with 5 min ischemia followed by 5 min reperfusion either immediately preceded 30 or 90 min ischemia/120 min reperfusion or was applied 24 h before. In study 1 and 2, optimal protection was achieved with 5 min or two cycles of 2 min preconditioning ischemia (CK=3.06±0.31 and 2.89±0.02; MTT=0.56±0.05 and 0.47±0.09, respectively vs. CK=5.56±0.52 and MTT=0.18±0.04 in ischemia alone group; P<0.05). In study 3, protection was observed 2 h after preconditioning (CK=3.43±0.22 and MTT=0.46±0.09; P<0.01 vs. ischemia alone group) but it was lost beyond 2 h (CK=6.30±0.56 and MTT=0.16±0.02 after 3 h; P=NS vs. ischemia alone group). In study 4, protection was observed 24 h following preconditioning when the atrial specimens were exposed to 30 min ischemia (CK=2.96±0.38 and MTT=0.61±0.01 vs. CK=4.56±0.26 and MTT=0.43±0.02 in ischemia alone group, P<0.05); however, when the period of ischemia was extended to 90 min the beneficial effect of preconditioning was lost (CK=10.28±0.5 and MTT=0.11±0.05 vs. CK=9.56±0.62 and MTT=0.104±0.05 in ischemia alone group, P=NS). Conclusions: In the isolated human myocardium maximal protection induced by preconditioning is achieved by a total 4–5 min ischemic stimulus, an effect that is lost beyond 2 h of its application. Two windows of protection were identified, the first (2 h) being more potent than the second (24 h).
KEYWORDS Ischemia; Preconditioning
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. K. Lai, J. Linares-Palomino, B. Nadal-Ginard, and M. Galinanes Bone marrow cell-induced protection of the human myocardium: Characterization and mechanism of action J. Thorac. Cardiovasc. Surg., December 1, 2009; 138(6): 1400 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Lai, K.-L. Ang, W. Rathbone, N. J. Harvey, and M. Galinanes Randomized controlled trial on the cardioprotective effect of bone marrow cells in patients undergoing coronary bypass graft surgery Eur. Heart J., October 1, 2009; 30(19): 2354 - 2359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Golomb, A. Nyska, and H. Schwalb Occult Cardiotoxicity--Toxic Effects on Cardiac Ischemic Tolerance Toxicol Pathol, August 1, 2009; 37(5): 572 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Elami, Z. Gavish, A. Korach, E. Houminer, A. Schneider, H. Schwalb, and A. Arav Successful restoration of function of frozen and thawed isolated rat hearts J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Golomb, A. Schneider, E. Houminer, J. Dunnick, G. Kissling, J. B. Borman, A. Nyska, and H. Schwalb Occult Cardiotoxicity: Subtoxic Dosage of Bis(2-chloroethoxy)methane Impairs Cardiac Response to Simulated Ischemic Injury Toxicol Pathol, April 1, 2007; 35(3): 383 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Martou, C. A. O'Blenes, N. Huang, S. E. McAllister, P. C. Neligan, H. Ashrafpour, C. Y. Pang, and J. E. Lipa Development of an in vitro model for study of the efficacy of ischemic preconditioning in human skeletal muscle against ischemia-reperfusion injury J Appl Physiol, November 1, 2006; 101(5): 1335 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hassouna, M. Loubani, B. M. Matata, A. Fowler, N. B. Standen, and M. Galinanes Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium Cardiovasc Res, February 1, 2006; 69(2): 450 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Berg, B. O. Christensen, S. Aagaard, T. B.N. Christensen, D. A. Steinbruchel, and J. M. Hasenkam Ischaemic preconditioning causes increased myocardial vascular resistance but no myocardial contractility changes in pigs after OPCAB Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 207 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ad, A. Schneider, I. Khaliulin, J. B. Borman, and H. Schwalb Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: In vitro study in human myocardium J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 41 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hassouna, B. M. Matata, and M. Galinanes PKC-{epsilon} is upstream and PKC-{alpha} is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1418 - C1425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Faust, A. K. Gamperl, and K. J. Rodnick All rainbow trout (Oncorhynchus mykiss) are not created equal: intra-specific variation in cardiac hypoxia tolerance J. Exp. Biol., February 22, 2004; 207(6): 1005 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Loubani, A. Hassouna, and M. Galinanes Delayed preconditioning of the human myocardium: signal transduction and clinical implications Cardiovasc Res, February 15, 2004; 61(3): 600 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Deja, K. S. Golba, M. Kolowca, K. Widenka, J. Biernat, and S. Wos Diazoxide provides protection to human myocardium in vitro that is concentration dependent Ann. Thorac. Surg., January 1, 2004; 77(1): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schneider, N. Ad, U. Izhar, I. Khaliulin, J. B. Borman, and H. Schwalb Protection of myocardium by cyclosporin A and insulin: in vitro simulated ischemia study in human myocardium Ann. Thorac. Surg., October 1, 2003; 76(4): 1240 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bartling, I. Friedrich, R.-E. Silber, and A. Simm Ischemic preconditioning is not cardioprotective in senescent human myocardium Ann. Thorac. Surg., July 1, 2003; 76(1): 105 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ghosh and M. Galinanes Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 133 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Loubani, S. Ghosh, and M. Galinanes The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 143 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Loubani and M. Galinanes Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: Role of mitochondrial adenosine triphosphate-dependent potassium channels J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A Kloner, M. T Speakman, and K. Przyklenk Ischemic preconditioning: a plea for rationally targeted clinical trials Cardiovasc Res, August 15, 2002; 55(3): 526 - 533. [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Gamperl, A. E. Todgham, W. S. Parkhouse, R. Dill, and A. P. Farrell Recovery of trout myocardial function following anoxia: preconditioning in a non-mammalian model Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1755 - R1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Loubani and M. Galinanes {{alpha}}1-Adrenoceptors during simulated ischemia and reoxygenation of the human myocardium: Effect of the dose and time of administration J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 103 - 112. [Abstract] [Full Text] [PDF]
|
|